This was recently confirmed in newborns by Diaz et al.10 We hypothesised that there would be a positive correlation between the interpeak wave (I-V) interval as measured by auditory brain stem evoked response and the ratio of umbilical cord blood arterial:venous lignocaine concentrations in infants bom after maternal epidural anaesthesia. The wave (I-V) interpeak interval rather than the absolute wave V latency was chosen because wave V latency may be affected by external factors-for example, fluid in the ear canal. On the other hand, the wave
Lignocaine, one of the most widely used agents in epidural anaesthesia, has been associated with abnormal neurobehavioural responses in the newborn.1 2 In 1974, Scanlon et al reported that lignocaine adversely affected the neonatal behavioural examination (as measured by the Scanlon early neonatal behavioural scale) performed at 2 to 6 hours of life.3 Subsequent studies failed to confirm these observations. In general, however, these studies lacked both control for confounding variables and appropriate data analyses.4 5 This was recently confirmed in newborns by Diaz et al. 10 We hypothesised that there would be a positive correlation between the interpeak wave (I-V) interval as measured by auditory brain stem evoked response and the ratio of umbilical cord blood arterial:venous lignocaine concentrations in infants bom after maternal epidural anaesthesia. The wave (I-V) interpeak interval rather than the absolute wave V latency was chosen because wave V latency may be affected by external factors-for example, fluid in the ear canal. On the other hand, the wave I-V interval is a direct, uncontaminated measure of neural conduction along the auditory pathways. Samples of umbilical cord arterial and venous plasma were assayed for lignocaine using fluorescence immune assay. A segment of umbilical cord was double clamped at delivery, the vessels were identified, and samples were aspirated from each vessel. After centrifugation the plasma was transferred to plastic test tubes and frozen at -48°C until assay could be accomplished. The results were expressed as the ratio of umbilical artery:umbilical venous lignocaine concentrations.
Data were analysed by the Wilcoxon signed rank test; we used a non-parametric statistical test as it could not be assumed that the data were normally distributed (small sample size). The test was two sided. Simple linear regression was also done to study the association between the arterial: venous ratio (predictor variable) and the interpeak (wave I-V) interval measurement (response variable).
Results
Ten mothers and infants were enrolled in and completed the study. The mean (SD) maternal lignocaine dose was 0x023 (0x004) mmol/kg body weight. Mean (SD) birth weight of the study infants was 3157 (421 g) and their mean (SD) gestational age was 39 (1-1) weeks. All were appropriately grown for gestational age. Median Apgar scores at 1 and 5 minutes were 8 (range 7-9) and 9 (all infants), 
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group.bmj.com on October 21, 2017 -Published by http://adc.bmj.com/ Downloaded from cats was studied using the auditory brain stem evoked response by Javel et al. 8 The auditory brain stem evoked response was recorded after systemic infusion of lignocaine at varying rates. Lignocaine's principal effect on the auditory brain stem evoked response was to lengthen all interpeak intervals without reduction of amplitude. The effects were reversible as the drug concentration fell. They hypothesised that lignocaine produced a uniform, dose dependent shift in central nervous impulse conduction times. They further hypothesised that this shift should have its greatest effect on sensory activities requiring higher central processing, such as speech discrimination. Ruth et al recorded the auditory brain stem evoked responses of six healthy male volunteers during intravenous infusion of lignocaine and observed both significant decreases in wave V amplitude and increases in wave V latency. 9 More recently, Diaz et al examined the effect of maternal lignocaine anaesthesia on the auditory brain stem evoked response in 16 infants born at full term.'0 Eight infants were delivered by caesarean section and exposed to lignocaine, while eight were delivered vaginally without maternal anaesthesia. An auditory brain stem evoked response was obtained on all infants at 3-5 hours, and all infants were tested at 30, 60, and 90 dB. A delay in the wave I-V interpeak interval was seen at 90 dB in both ears for the neonates exposed to lignocaine. Surprisingly, no effect was seen at 60 dB. As distortion and cross over to the other ear are more likely at 90 dB, the validity of these findings is not clear. In contrast to our findings, no correlation between lignocaine concentrations and prolongation of wave I-V interpeak intervals was seen. This lack of correlation may be explained by their using absolute umbilical artery or vein lignocaine concentrations as opposed to the arterial:venous ratio that more accurately reflects tissue lignocaine concentration.2 In our study the mean arterial:venous ratio was greater than 1, indicating that equilibrium between the infants' tissue and blood lignocaine concentrations had been reached. It is possible that the lignocaine arterial: venous ratios were lower in the infants studied by Diaz et al. An additional difference from our study was that Diaz et al reported no follow up auditory brain stem evoked response results to strengthen the causal hypothesis. Nevertheless, both studies suggest an effect of lignocaine.
Our observational study is limited because of the lack of a control group. The ideal control group would include infants delivered in a similar manner -that is, caesarean section without anaesthesia, which is not possible. All low risk elective caesarean sections are carried out under epidural anaesthesia in our hospital, so we were unable to identify a comparison group also delivered by caesarean section. Even if we were to disregard the possible effect of mode of delivery on auditory brain stem evoked response testing, significant plasma lignocaine concentrations have been found after its use for paracervical block and episiotomy.15 16 We could not, therefore, identify a sufficient number of deliveries for which no anaesthetic agent was used.
Despite the lack of a control group, our data suggest a causal relationship between epidural lignocaine anaesthesia and alteration in the auditory brain stem evoked response in that (a) there was an association, with a significant dose response 
